Enlivex Ltd. SEC filings ENLV
Enlivex Ltd. has 419 filings in SEC EDGAR's recent list, going back to Feb 7, 2014. Its latest annual report, Form 20-F, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 13, 2026 | — |
| EFFECT | Filing | Apr 30, 2026 | — |
| CORRESP | Letter to the SEC | Apr 28, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| EFFECT | Filing | Jan 2, 2026 | — |
| CORRESP | Letter to the SEC | Dec 30, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2025 | — |
| EFFECT | Filing | May 12, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| EFFECT | Filing | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| UPLOAD | Letter from the SEC | May 2, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Jan 31, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2019 | — |
| EFFECT | Filing | Jul 9, 2019 | — |
| CORRESP | Letter to the SEC | Jul 5, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2019 | — |
| EFFECT | Filing | Jun 21, 2019 | — |
| CORRESP | Letter to the SEC | Jun 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2019 | — |
| RW | Filing | Apr 6, 2017 | — |
| D | Filing | Apr 1, 2016 | — |
| EFFECT | Filing | Aug 12, 2015 | — |
| CORRESP | Letter to the SEC | Aug 10, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2015 | — |
| CERTNAS | Auto-generated paper document | Jul 30, 2014 | — |
| EFFECT | Filing | Jul 30, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| 8-A12B | Filing | Jul 28, 2014 | — |
| CORRESP | Letter to the SEC | Jul 25, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2014 | — |
| CORRESP | Letter to the SEC | Apr 7, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2014 | — |
| CORRESP | Letter to the SEC | Mar 14, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2014 | — |
| D | Filing | Feb 13, 2014 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- ENLV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1596812
- Former names
- Enlivex Therapeutics Ltd. (until Feb 10, 2026); Bioblast Pharma Ltd. (until Mar 18, 2019); BIO BLAST PHARMA LTD. (until Sep 12, 2016)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.